PsyChild. Tracking clinical psychedelics in minors.
PsyChild is a database of clinical research with psychedelics and related compounds in minors. Its main aim is to provide a growing bibliography on this multidisciplinary field for researchers, research subjects, patients, guardians, clinicians, critics, and external experts. Some of the provided records contain accounts of violence, homophobia, and unethical conduct, underscoring the urgent need to grapple with the difficult history of this field. Due to the cross-pollination of different research strands in this multidisciplinary field, PsyChild not only includes “classic” psychedelics but also related compounds such as entactogens like mCPP and αET, deliriants like atropine and scopolamine, and dissociatives like ketamine and PCP. While PsyChild takes a neutral stance on the question whether psychedelic-assisted psychotherapy (PAP) should be provided to minors, we do call for evidence-based, harm-reduction-oriented PAP protocols designed for minors in case research or treatment should be carried out. Inclusion in the database does not equal endorsement. PsyChild is committed to an open science approach and welcomes suggestions and submissions.
On mobile devices, we recommend using the Desktop site instead of the default mobile version for better viewing experience.
Philipp Rühr is responsible for curating new data for PsyChild, while this webpage is written and maintened by Peter T. Rühr. Issues can be reported at PsyChild's GitHub page.Please cite this website as:
PsyChild. Tracking Clinical Psychedelics in Minors (2023). Retrieved <yyyy\mm\dd> from https//PsyChild.info. doi: 10.5281/zenodo.10020023.
Download buttons are provided below (clipboard, csv, or Excel).
Mobile visibility of PsyChild on cell phones is improved when you enable the 'Desktop version' manually on your phone browser.
Published
Archival
Publication pending
Discontinued/Uncertain
Current/Ongoing
*1 For multicenter-studies, only the main site is listed.
*2 Due to the large number of available studies with ketamine and ketofol, references to the use of these compounds have only been included if they either address symptoms of pediatric anesthesia emergence delirium (PAED), or if they have been conducted in a psychiatric context.
*3 Studies with cannabinoids have only been included if the ratio of psychoactive cannabinoids vs. non psychoactive cannabinoids has been higher than 1:20.
*4 As Treatment-Resistant Depression (TRD) is not clearly defined, it is labeled as MDD in the indication columns.
Download buttons are provided below (clipboard, csv, or Excel).
Published
Archival
Publication pending
Discontinued/Uncertain
Current/Ongoing
*1 For multicenter-studies, only the main site is listed.
*2 Due to the large number of available studies with ketamine and ketofol, references to the use of these compounds have only been included if they either address symptoms of pediatric anesthesia emergence delirium (PAED), or if they have been conducted in a psychiatric context.
*3 Studies with cannabinoids have only been included if the ratio of psychoactive cannabinoids vs. non psychoactive cannabinoids has been higher than 1:20.
*4 As Treatment-Resistant Depression (TRD) is not clearly defined, it is labeled as MDD in the indication columns.
Download buttons are provided below (clipboard, csv, or Excel).
Published
Archival
Publication pending
Discontinued/Uncertain
Current/Ongoing
*1 For multicenter-studies, only the main site is listed.
*2 Due to the large number of available studies with ketamine and ketofol, references to the use of these compounds have only been included if they either address symptoms of pediatric anesthesia emergence delirium (PAED), or if they have been conducted in a psychiatric context.
*3 Studies with cannabinoids have only been included if the ratio of psychoactive cannabinoids vs. non psychoactive cannabinoids has been higher than 1:20.
*4 As Treatment-Resistant Depression (TRD) is not clearly defined, it is labeled as MDD in the indication columns.
Site Notice
Information provided according to Sec. 5 German Telemedia Act (TMG)Philipp Rühr
Schlesische Straße 5
10997 Berlin
Contact
Telephone: +49 163 843 4522Email: philippruehr@gmail.com
Preferred mention for citations:
PsyChild. Tracking Clinical Psychedelics in Minors (2023). Retrieved <yyyy\mm\dd> from https//PsyChild.info. doi: 10.5281/zenodo.10020023.Dispute Resolution
The European Commission provides a platform for online dispute resolution (OS): https://ec.europa.eu/consumers/odr. Please find our email in the impressum/legal notice. We do not take part in online dispute resolutions at consumer arbitration boards.Liability for Contents
As service providers, we are liable for own contents of these websites according to Sec. 7, paragraph 1 German Telemedia Act (TMG). However, according to Sec. 8 to 10 German Telemedia Act (TMG), service providers are not obligated to permanently monitor submitted or stored information or to search for evidences that indicate illegal activities.Legal obligations to removing information or to blocking the use of information remain unchallenged. In this case, liability is only possible at the time of knowledge about a specific violation of law. Illegal contents will be removed immediately at the time we get knowledge of them.
Liability for Links
Our offer includes links to external third party websites. We have no influence on the contents of those websites, therefore we cannot guarantee for those contents. Providers or administrators of linked websites are always responsible for their own contents.The linked websites had been checked for possible violations of law at the time of the establishment of the link. Illegal contents were not detected at the time of the linking. A permanent monitoring of the contents of linked websites cannot be imposed without reasonable indications that there has been a violation of law. Illegal links will be removed immediately at the time we get knowledge of them.
Copyright
Contents and compilations published on these websites by the providers are subject to German copyright laws. Reproduction, editing, distribution as well as the use of any kind outside the scope of the copyright law require a written permission of the author or originator. Downloads and copies of these websites are permitted for private use only. The commercial use of our contents without permission of the originator is prohibited.Copyright laws of third parties are respected as long as the contents on these websites do not originate from the provider. Contributions of third parties on this site are indicated as such. However, if you notice any violations of copyright law, please inform us. Such contents will be removed immediately.